Shenkman Capital Management Inc has filed its 13F form on August 08, 2024 for Q2 2024 where it was disclosed a total value porftolio of $74.3 Million distributed in 114 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Lending Tree, Inc. with a value of $19.7M, Diamond Offshore Drilling, Inc. with a value of $18.9M, Summit Midstream Partners, LP with a value of $16.7M, Invesco ETF Tr Ii Sr Ln ETF with a value of $8.98M, and Spdr Bloomberg Short Term High with a value of $5.75M.
Examining the 13F form we can see an decrease of $43.6M in the current position value, from $118M to 74.3M .
Shenkman Capital Management Inc is based out at New York, NY
Below you can find more details about Shenkman Capital Management Inc portfolio as well as his latest detailed transactions.
Portfolio value
$74.3 Million
$35.6 Million
$19.7 Million
$16 Million
$2.4 Million
$651,000
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 23.14%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 8.83%
-
$0
0.0% of portfolio
-
Q2 2024
Added 40.52%
-
$0
0.0% of portfolio
-
Q2 2024
Added 7.75%
-
$0
0.0% of portfolio
-
Q2 2024
Added 6.58%
-
$0
0.0% of portfolio
-
Q2 2024
Added 51.06%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 35.96%
-
$0
0.0% of portfolio
-
Q4 2023
Added 9.72%
-
$0
0.0% of portfolio
-
Q2 2024
Added 37.23%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 75.59%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 72.65%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 32.73%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 50.25%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.71%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 1.14%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 10.51%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 71.6%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 2.13%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 11.86%
-
$0
0.0% of portfolio
-
Q1 2024
Added 52.0%
-
$0
0.0% of portfolio
-
Q2 2024
Added 3.27%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 1.4%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 2.77%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 11.19%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 10.69%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 140.0%
-
$0
0.0% of portfolio
-
Q2 2024
Added 94.6%
-
$0
0.0% of portfolio
-
Q2 2024
Added 147.88%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 1.44%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 58.4%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 34.04%
-
$0
0.0% of portfolio
-
Q2 2024
Added 7.01%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 16.87%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.8%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 13.7%
-
$0
0.0% of portfolio
-
Q2 2024
Added 2.38%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 7.89%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 1.27%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 39.21%
Ironwood Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 161.19%
-
$0
0.0% of portfolio
-
Q2 2024
Added 2.83%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 68.01%
-
$0
0.0% of portfolio
-
Q2 2024
Added 5.22%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 18.51%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 104.82%
